Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel-AML Characterization Test sale cost 2520 AED
Calcitonin Stimulation by Calcium - Pentagastrin Test sale cost 2380 AED Calcitonin Stimulation by Calcium - Pentagastrin Test Cost 2,800 د.إ Original price was: 2,800 د.إ.2,380 د.إCurrent price is: 2,380 د.إ.
Minimal Residual Disease MRD Analysis for B-ALL Test sale cost 2430 AED Minimal Residual Disease MRD Analysis for B-ALL Test Cost 2,700 د.إ Original price was: 2,700 د.إ.2,430 د.إCurrent price is: 2,430 د.إ.
Sale!

Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel-AML Characterization Test Cost

Original price was: 2,800 د.إ.Current price is: 2,520 د.إ.

-10%

Immunophenotyping by Flow Cytometry is a powerful diagnostic tool used in the characterization of Acute Myeloid Leukemia (AML), a type of cancer that affects the blood and bone marrow. This sophisticated test involves the analysis of cells to identify specific markers or antigens present on their surface, which can provide detailed information about the subtype of leukemia, thus guiding treatment decisions.

At DNA Labs UAE, the AML Characterization Test is offered as part of their leukemia diagnostic panel. This test is meticulously designed to detect and quantify the presence of various markers associated with AML, enabling precise diagnosis and classification of the disease. The process involves collecting a sample of blood or bone marrow from the patient, which is then subjected to flow cytometry analysis. This technique allows for the rapid analysis of thousands of cells in a short period, providing a comprehensive profile of the cellular characteristics present.

The cost of the AML Characterization Test at DNA Labs UAE is set at 2520 AED. This investment covers the intricate process of cell analysis, utilization of advanced flow cytometry equipment, and the expertise of specialized medical professionals who interpret the results. The outcome of this test is critical for determining the most effective treatment plan for patients with AML, offering hope for a tailored approach to combat this challenging disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOPHENOTYPING BY FLOW CYTOMETRY LEUKEMIA DIAGNOSTIC PANEL-AML CHARACTERIZATION Test

Test Cost: AED 2520.0

Test Name: IMMUNOPHENOTYPING BY FLOW CYTOMETRY LEUKEMIA DIAGNOSTIC PANEL-AML CHARACTERIZATION Test

Test Components: Flow Cytometry

Price: 2520.0 AED

Sample Condition: 3 mL (2 mL min.) whole blood each in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium heparin) tube AND Aspirate Smear. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE.

Clinical History: Clinical history is mandatory.

Report Delivery: Sample Daily by 9 am; Report Same day

Method: Flow Cytometry

Test Type: Leukemias

Doctor: Oncologist, Hematologist

Test Department: FLOW CYTOMETRY

Pre Test Information: Clinical history is mandatory.

Test Details:

Immunophenotyping by flow cytometry is a diagnostic test used to identify and characterize different types of leukemia, specifically acute myeloid leukemia (AML). The test involves the use of flow cytometry, a technique that analyzes the physical and chemical characteristics of individual cells as they flow in a fluid stream through a laser beam.

The leukemia diagnostic panel-AML characterization test aims to identify specific markers or antigens expressed on the surface of leukemic cells. These markers help differentiate between different types of leukemia and provide important information for diagnosis, prognosis, and treatment decisions.

The test involves obtaining a blood or bone marrow sample from the patient, which is then processed and stained with fluorescent antibodies specific to different cell surface markers. The stained sample is then analyzed using flow cytometry, which measures the fluorescence emitted by each individual cell. This allows for the identification and quantification of different cell populations based on their antigen expression patterns.

The leukemia diagnostic panel-AML characterization test typically includes a panel of antibodies that target markers commonly found on AML cells, such as CD13, CD33, CD34, CD117, and HLA-DR. By analyzing the expression of these markers, the test can help determine the subtype of AML and provide valuable information about the prognosis and potential treatment options for the patient.

Overall, immunophenotyping by flow cytometry is a powerful tool in the diagnosis and characterization of leukemia, including AML. It provides important information that can guide treatment decisions and improve patient outcomes.

Test Name IMMUNOPHENOTYPING BY FLOW CYTOMETRY LEUKEMIA DIAGNOSTIC PANEL-AML CHARACTERIZATION Test
Components
Price 2520.0 AED
Sample Condition 3 mL (2 mL min.) whole blood each in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium heparin) tube AND Aspirate Smear. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Clinical history is mandatory.
Report Delivery Sample Daily by 9 am; Report Same day
Method Flow Cytometry
Test type Leukemias
Doctor Oncologist, Hematologist
Test Department: FLOW CYTOMETRY
Pre Test Information Clinical history is mandatory.
Test Details

Immunophenotyping by flow cytometry is a diagnostic test used to identify and characterize different types of leukemia, specifically acute myeloid leukemia (AML). The test involves the use of flow cytometry, a technique that analyzes the physical and chemical characteristics of individual cells as they flow in a fluid stream through a laser beam.

The leukemia diagnostic panel-AML characterization test aims to identify specific markers or antigens expressed on the surface of leukemic cells. These markers help differentiate between different types of leukemia and provide important information for diagnosis, prognosis, and treatment decisions.

The test involves obtaining a blood or bone marrow sample from the patient, which is then processed and stained with fluorescent antibodies specific to different cell surface markers. The stained sample is then analyzed using flow cytometry, which measures the fluorescence emitted by each individual cell. This allows for the identification and quantification of different cell populations based on their antigen expression patterns.

The leukemia diagnostic panel-AML characterization test typically includes a panel of antibodies that target markers commonly found on AML cells, such as CD13, CD33, CD34, CD117, and HLA-DR. By analyzing the expression of these markers, the test can help determine the subtype of AML and provide valuable information about the prognosis and potential treatment options for the patient.

Overall, immunophenotyping by flow cytometry is a powerful tool in the diagnosis and characterization of leukemia, including AML. It provides important information that can guide treatment decisions and improve patient outcomes.

SKU: TEST-4888 Category:

Related products